NEW ZEALAND MEDICAL JOURNAL最新文献_第10页

Lead pencil: a case of intractable abdominal pain secondary to lead poisoning. 铅中毒致顽固性腹痛1例。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6626

Amy Van der Sluis, Kirsty Sutherland

引用次数: 0

"Front-load" your co-design-evidence in mental health supports it. “预先载入”你在精神健康方面的共同设计证据支持它。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6728

Clive Bensemann, Karen O'Keeffe, Arana Pearson, Jacqueline Ryan, Karl Wairama, Wi Keelan

{"title":"\"Front-load\" your co-design-evidence in mental health supports it.","authors":"Clive Bensemann, Karen O'Keeffe, Arana Pearson, Jacqueline Ryan, Karl Wairama, Wi Keelan","doi":"10.26635/6965.6728","DOIUrl":"10.26635/6965.6728","url":null,"abstract":"Co-design in quality improvement projects is well-established as an effective way of creating more consumer-centred, whānau-centred care, and to shape solutions that work for consumers as well as services. However, in practice, consumers of health services, families and whānau are often consulted after key decisions about project design are made. This can result in tokenism, missed opportunities for improvement and breached obligations to the Māori right to autonomy, self-determination and control of their own destiny as expressed in Article 2 of Te Tiriti o Waitangi. \"Front-loaded\" co-design was used in selection of project areas and project design in Te Tāhū Hauora - New Zealand Health Quality & Safety Commission's mental health quality improvement work and has been critical to success. With broad sector consultation, one area mental health consumers agreed was a priority for improvement was elimination of seclusion in mental health services, particularly for Māori who experienced significant health inequity in this area. This aim was considered unachievable by many in the sector at the time. However, the zero seclusion project has successfully contributed to reductions in rates of seclusion of all ethnicities, and continues to do so. \"Front-loaded\" co-design with Māori and consumer guidance is critical to this success. Furthermore, true co-design also ensures the mana motuhake and tino rangatiratanga (self-determination and control over one's own destiny) of Māori, and of all peoples who use our health services.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1610","pages":"105-111"},"PeriodicalIF":1.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Consequences of COVID-19 protection measures on children's respiratory health in Aotearoa New Zealand. 新冠肺炎防护措施对新西兰奥特罗阿地区儿童呼吸系统健康的影响

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6714

Claire O'Loughlin, Tali Uia, Cameron Grant, Kirsten Smiler, Marianna Churchward, Catherine Tu'akalau, Rochelle Ellison-Lupena, Mona Jeffreys

{"title":"Consequences of COVID-19 protection measures on children's respiratory health in Aotearoa New Zealand.","authors":"Claire O'Loughlin, Tali Uia, Cameron Grant, Kirsten Smiler, Marianna Churchward, Catherine Tu'akalau, Rochelle Ellison-Lupena, Mona Jeffreys","doi":"10.26635/6965.6714","DOIUrl":"10.26635/6965.6714","url":null,"abstract":"Aim: To explore the impact of COVID-19 protection measures on children's respiratory health in Aotearoa New Zealand.Method: Annual hospitalisation rates (2017/2018 to 2022/2023) for specific respiratory illnesses in children under age 15 years were calculated. Comparisons were made across time and age/sex/ethnicity groups.Results: Hospitalisation rates for respiratory illnesses were lower for all children in the years when COVID-19 protection measures were strictly enforced, followed by an increase in rates in subsequent years. There was an excess of hospitalisations for tamariki Māori and for Pacific children compared with non-Māori, non-Pacific children. Inequities in influenza that were present before the pandemic re-emerged rapidly following the relaxation of COVID-19 protection measures.Conclusion: Reducing the burden of respiratory illness in children is a key challenge for health delivery in Aotearoa New Zealand. The re-appearance of inequities across outcomes and age groups following the relaxation or removal of COVID-19 protection measures indicates the need for an effective strategy that embeds learnings from our pandemic response.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1610","pages":"74-92"},"PeriodicalIF":1.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The historical and projected prevalence of dysphagia in Aotearoa New Zealand. 新西兰奥特罗阿地区吞咽困难的历史和预测患病率。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6404

Philip Gunby, Josh McSkimming, Maggie-Lee Huckabee

{"title":"The historical and projected prevalence of dysphagia in Aotearoa New Zealand.","authors":"Philip Gunby, Josh McSkimming, Maggie-Lee Huckabee","doi":"10.26635/6965.6404","DOIUrl":"10.26635/6965.6404","url":null,"abstract":"Aim: To estimate the current prevalence of dysphagia in the Aotearoa New Zealand population and to project its prevalence to 2073.Methods: The current prevalence of dysphagia in Aotearoa New Zealand is computed from the prevalences of the aetiologies of dysphagia combined with the rates at which the aetiologies result in dysphagia. Projected dysphagia rates use autoregressive integrated moving average forecasting techniques combined with population projections from Statistics New Zealand and estimates of current and past prevalence rates of dysphagia.Results: The prevalence of dysphagia in Aotearoa New Zealand is estimated to have been approximately 1.78% in 2020, with the biggest aetiological contributors being stroke, Alzheimer's disease and other dementias, and gastroesophageal reflux disease. These three causes made up 81.5% of all estimated dysphagia cases in 2019. The prevalence rate of dysphagia in Aotearoa New Zealand is projected to rise to 2.54%, reflecting the ageing population.Conclusion: An increased prevalence of dysphagia will result in an increased healthcare burden, both from resources spent on treating dysphagia and complications stemming from undiagnosed and thus untreated dysphagia. Estimating the full extent of this increased burden is hampered by the absence of systematic, extensive and reliable records available relating to cases of dysphagia in Aotearoa New Zealand.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1610","pages":"39-51"},"PeriodicalIF":1.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical alert: arrival of terbinafine resistant Trichophyton indotineae in New Zealand. 临床警告：耐特比萘芬的indodoinetrichophyton抵达新西兰。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6815

Wendy P McKinney, Matthew R Blakiston, Sally A Roberts, Arthur J Morris

{"title":"Clinical alert: arrival of terbinafine resistant Trichophyton indotineae in New Zealand.","authors":"Wendy P McKinney, Matthew R Blakiston, Sally A Roberts, Arthur J Morris","doi":"10.26635/6965.6815","DOIUrl":"10.26635/6965.6815","url":null,"abstract":"Background: Over the past decade there has been a rapid emergence of a new dermatophyte species Trichophyton indotineae (T. indotineae) in the Indian subcontinent, with associated global spread. It is noted for extensive recalcitrant infections and high rates of terbinafine resistance that are changing treatment paradigms for tinea infection.Aim: To report on the epidemiology of dermatophyte infections from the National Mycology Reference Laboratory at Auckland City Hospital and the arrival of T. indotineae in New Zealand.Methods: This was a retrospective review of laboratory data from January 2017 to August 2024. Antifungal susceptibility was performed by disc testing. Species identification was performed by phenotypic methods and for a limited number of isolates by DNA sequence analysis.Results: There were 961 dermatophytes identified. Trichophyton rubrum was the most common species, accounting for 72% of all isolates. There were 85 (9%) confirmed or probable T. indotineae identified from 63 individuals. These included both Auckland isolates and isolates referred from laboratories around the country. Of the 49 T. indotineae isolates that had antifungal susceptibility testing performed, only 30 (61%) were susceptible to terbinafine, while 45 (92%) were susceptible to itraconazole.Conclusions: Terbinafine resistant T. indotineae has arrived in New Zealand. To assist appropriate management, practitioners encountering extensive tinea infection, particularly if failing terbinafine treatment, should request culture, asking for full dermatophyte identification and susceptibility testing. Itraconazole is the recommended treatment for T. indotineae, and up to 12 weeks duration may be required.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1610","pages":"31-38"},"PeriodicalIF":1.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Firearms Review threatens to walk back gains in public safety. 《枪支评论》可能会使公共安全方面取得的成果付之一篑。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6873

Jonty Morreau, Christopher Wakeman

引用次数: 0

Attempt CPR-language matters inside our hospitals. 尝试在我们医院里进行心肺复苏术。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6769

Tammy Pegg, Alex Psirides, Niamh Berry-Kilgour, Jane Goodwin, Joshua Lakin, Kate Grundy

引用次数: 0

Hepatitis C virus seroprevalence in defined populations in New Zealand: data from a general practice-based screening programme. 新西兰特定人群的丙型肝炎病毒血清流行率：来自基于一般实践的筛查规划的数据

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6596

Ho Tuan Tiong, Arlo Upton, Angelle Lockie, Kirsty Moore, Catherine A M Stedman

{"title":"Hepatitis C virus seroprevalence in defined populations in New Zealand: data from a general practice-based screening programme.","authors":"Ho Tuan Tiong, Arlo Upton, Angelle Lockie, Kirsty Moore, Catherine A M Stedman","doi":"10.26635/6965.6596","DOIUrl":"10.26635/6965.6596","url":null,"abstract":"Aim: To assess the hepatitis C virus (HCV) seroprevalence data for defined regions in New Zealand.Methods: Email or mobile phone text invitations were sent out to adults enrolled with three participating general practices in different parts of New Zealand. Patients who provided informed consent were instructed to self-present for HCV blood tests. Patients with positive HCV antibodies had reflex testing of HCV antigen and ribonucleic acid (RNA) viral load.Results: In total, 26,247 invitations were issued. Of these, 1,368 (5.2%) people gave informed consent and 1,021 patients (3.9%) had HCV blood tests. Ten out of 1,021 (0.98%; 95% confidence interval [CI] 0.51-1.82%) tested positive for HCV antibodies, of whom two (0.2%; 95% CI <0.01-0.76%) had positive antigen and elevated RNA viral load. The proportion of NZ Māori and Pacific people was low, at 3.8% and 0.4%, respectively. Volunteers with a high deprivation index were under-represented (3% from New Zealand Index of Deprivation deciles 9 and 10).Conclusions: The HCV viraemia prevalence in this general practice-based screening programme is 0.2%, which is lower than previous estimates. This may have implications for appropriate resource allocations and the determination of the best strategies to find new HCV infections. Participation rates of people with high deprivation indexes or who were NZ Māori and Pacific people were low, suggesting that a tailored screening approach is needed.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1610","pages":"52-59"},"PeriodicalIF":1.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clumsy child: what are we missing? 笨孩子：我们错过了什么？

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6610

Jeyasakthy Saniasiaya

引用次数: 0

Disparities in patient mortality following intensive care admission due to adult community-acquired sepsis in Aotearoa New Zealand, 2009-2019. 2009-2019年新西兰奥特罗阿地区成人社区获得性败血症重症监护入院后患者死亡率的差异

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-02-28 DOI: 10.26635/6965.6801

Sharla McTavish, Alice Hyun Min Kim, Amanda Kvalsvig, June Atkinson, Colin McArthur, Michael G Baker

{"title":"Disparities in patient mortality following intensive care admission due to adult community-acquired sepsis in Aotearoa New Zealand, 2009-2019.","authors":"Sharla McTavish, Alice Hyun Min Kim, Amanda Kvalsvig, June Atkinson, Colin McArthur, Michael G Baker","doi":"10.26635/6965.6801","DOIUrl":"10.26635/6965.6801","url":null,"abstract":"Aim: To characterise patient mortality risk following intensive care unit (ICU) admitted community-acquired sepsis (CAS) in Aotearoa New Zealand (Aotearoa), comparing in-hospital and post-discharge mortality and associated risk factors.Methods: We examined de-identified, linked ICU-admitted adult patient data from ICU sites in Aotearoa retrieved from the Australian and New Zealand Intensive Care Society's CORE adult patient database (ANZICS-CORE-APD) between 2009 and 2019. Patients were followed from ICU admission to death or 365 days post-hospital discharge alive, using descriptive, survival and regression analyses. The outcomes of interest were in-hospital mortality and post-discharge mortality during the first 365 days.Results: In-hospital mortality was 16.3%. Post-discharge mortality was 3.6% by 30 days after discharge, 9.1% by 180 days and 12.9% by 365 days. There was no significant difference in in-hospital mortality risk by ethnicity or New Zealand Index of Deprivation quintile of usual residence. By contrast, significant differences in post-discharge survival were observed by ethnicity, area deprivation quintile and presence of severe comorbidities, particularly for Māori usually resident in high-deprivation areas.Conclusions: There was no evidence of associations between in-hospital mortality and ethnicity or socio-economic deprivation; however, these associations become marked post-discharge. Interventions should be implemented to support early identification and management of CAS and address health inequities following hospital discharge.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1610","pages":"13-30"},"PeriodicalIF":1.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0